Investigational Site Number :1560012

Beijing 100053

0 studies enrolling now · 4 studies all time

What they study most

Chronic Obstructive Pulmonary Disease, Non-relapsing Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Relapsing Multiple Sclerosis

Studies at this site

• A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD — Running, not enrolling
• Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS) — Completed
• Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 1) — Completed
• Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (HERCULES) — Completed